The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK.

Rosario, D.J. orcid.org/0000-0002-9086-3592, Davey, P., Green, J. et al. (4 more authors) (2016) The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK. World Journal of Urology. pp. 1-9. ISSN 0724-4983

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2016 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Keywords: ADT; Cardiovascular; Degarelix; GnRH; Prostate cancer; UK
Dates:
  • Published: 20 April 2016
  • Accepted: 13 February 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 12 Jul 2016 08:32
Last Modified: 18 Oct 2016 14:30
Published Version: http:dx.doi.org/10.1007/s00345-016-1818-2
Status: Published
Publisher: Springer Verlag
Refereed: Yes
Identification Number: https://doi.org/10.1007/s00345-016-1818-2
Related URLs:

Share / Export

Statistics